NeurologyOnline.net

Neurology Xagena

Xagena Mappa
Medical Meeting
Xagena Salute
Onco News

The humanized monoclonal antibody Galcanezumab ( Emgality ), which binds to calcitonin gene‐related peptide ( CGRP ), has been evaluated for migraine prevention. The aim of the post‐hoc analyses w ...


New investigational data from a late-stage study has shown that Teriflunomide ( Aubagio ) significantly slows whole brain volume loss ( atrophy ) compared with placebo in patients with a first clinic ...


Brain injury after non-fatal cardiac arrest Cardiac arrest occurs in two different settings, in-hospital and out-of-hospital, with completely different prognosis, for obvious reasons. As cardiac ...


Multiple sclerosis ( MS ) is a chronic neuroinflammatory condition of the central nervous system ( CNS ). It is a major cause of neurological disability in young adults, particularly women. What trig ...


Combining medication that lowers blood pressure with medication that lowers cholesterol reduced first-time strokes by 44%, according to research presented at the American Stroke Association's Internat ...


The objective of a study was to investigate the kinetics and metabolism of Caffeine in serum from patients with Parkinson disease and controls using liquid chromatography–mass spectrometry. Levels ...


Fremanezumab ( ‎Ajovy ) is a monoclonal antibody directed against calcitonin-gene-related peptide ( CGRP ), a validated target for migraine preventive therapy. In two previous phase 2 studies, Frema ...


Teriflunomide ( Aubagio ) has a well characterized safety and tolerability profile that is consistent across phase II and III studies in the Teriflunomide clinical development program. Overall, adv ...


For the first time, researchers have found a connection between abnormalities in how the brain breaks down glucose and the severity of the signature amyloid plaques and tangles in the brain, as well a ...


There is increasing evidence that links perturbed sphingolipid metabolism to a range of different neurodegenerative conditions including Huntington’s disease ( HD ). Researchers have consolidated t ...


A new analysis from a pivotal study highlighting the efficacy of Erenumab in patients with 15 or more headache days a month ( chronic migraine ) and a recent history of acute migraine medication overu ...


New analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology ( AAN) in Boston, Massachusetts, were ...


Although Levodopa remains the most effective oral pharmacotherapy for Parkinson disease ( PD ), its use is often limited by wearing off effect and dyskinesias. Management of such complications continu ...


The results of a national survey aimed at quantifying the current level of diffusion of Levodopa and Carbidopa intestinal gel ( LCIG ) in Italy, were reported. Sixty Parkinson's disease specialists ...


Phase III RADIANCE trial, evaluating the efficacy and safety of Ozanimod, an investigational oral, selective S1P 1 and 5 receptor modulator, in patients with relapsing multiple sclerosis ( RMS ), met ...